Response to: Comparison between follitropin delta and follitropin alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!

Affiliations

Comment

Bernadette Mannaerts. Reprod Biomed Online. 2022 Sep.

. 2022 Sep;45(3):625.

doi: 10.1016/j.rbmo.2022.03.025. Epub 2022 Apr 6.

¹ Reproductive Medicine and Maternal Health, Ferring Pharmaceuticals, Copenhagen, Denmark.

No abstract available

Comment on

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.
Višnová H, Papaleo E, Martin FS, Koziol K, Klein BM, Mannaerts B. Višnová H, et al. Reprod Biomed Online. 2021 Dec;43(6):1019-1026. doi: 10.1016/j.rbmo.2021.08.024. Epub 2021 Sep 3. Reprod Biomed Online. 2021. PMID: 34756645
Comparison between follitropin-delta and follitropin-alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms!
Montenegro Gouveia S, Lispi M, D'Hooghe TM. Montenegro Gouveia S, et al. Reprod Biomed Online. 2022 Sep;45(3):623-624. doi: 10.1016/j.rbmo.2022.03.034. Epub 2022 Apr 9. Reprod Biomed Online. 2022. PMID: 35863940 No abstract available.